Phase II trial of subcutaneous interleukin-2, subcutaneous interferon-alpha, 5-fluorouracil and cis-retinoic acid in the treatment of renal cell carcinoma: final results of cancer biotherapy research group 94-10.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples